Clinical Trials
2 trialsNCT01423760 2016-10-06
Common Safety Follow-up Trial of Tecemotide (L-BLP25)
Merck KGaA, Darmstadt, Germany
Phase NA Terminated
NCT01094548 2016-02-22
Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy
Merck KGaA, Darmstadt, Germany
Phase 2 Completed